Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon May 14, 2023 6:40pm
238 Views
Post# 35447566

Ghost

Ghost

There was a post made by beenthere in response to me where he admonished me for messing with poof. Beenthere sais that shareholders were in a fight for their lives.

In my opinion, shareholders are not in a fight for their lives. I believe that shareholders may have already lost that fight.

Yes, it will be mid-month on Tuesday. That was guidance, not a prediction, from Bioasis. Bioasis likely could not be precise with that guidance. Foreclosure by Lind is the most likely way Bioasis will fail. To avoid that, Bioasis may be sold for nothing to Biodexa.

There are several ways that we know that shareholders are not fighting at all, let alone for their lives.

Shareholders had a chance to withhold votes for Rathjen and the BoD. Shareholders, in mass, failed to vote at all, assuring Rathjen's reelection. I have no idea why shareholders were so indifferent.

Secondly, there is no evidence, including from poof, that shareholders investigated Ladenburg Thalmann's (LT) activities during the last two years. 

Who did LT represent? Bioasis announced their collaboration with LT. LT was Midatech/Biodexa's rep for financings. LT brought all the placees into the financings. Has anybody looked at who the placees were for the latest financings?

Has anybody figured out the play that has happened at Biodexa since it went trading? Placees registered in the Cayman Islands? Other places of interest?

Could LT work for or with all three sides (four counting themselves) with there being conflicts of interests?

Did Bioasis figure anything out, or were they oblivious to it all? 

poof might tackle some of this stuff. Thousands of pages of filings, with all sorts of wondrous machinations described.

I'm not fighting for my life. I've already been killed off. I'm just a ghost of the company's past.

Mid-month isn't the execution date if you're already dead and don't know it.

jd



L

<< Previous
Bullboard Posts
Next >>